Navigation Links
USC receives $7.5M for Comprehensive Center of Excellence in Minority Health
Date:9/24/2007

Los Angeles, Calif., Sept. 24, 2007 In an effort to stem the rise of childhood obesity and related health risks, the University of Southern California (USC) has received a $7.5 million grant to launch a Comprehensive Center of Excellence in Minority Health. This is USCs first major grant from the National Center on Minority Health and Health Disparities (NCMHD), which is a part of the National Institutes of Health.

The focus of the center is to understand why obesity and associated factors increase the risk for certain diseases among minority populations. Directed by Michael Goran, Ph.D., professor of preventive medicine at the Keck School of Medicine of USC, the center will focus on reducing the risk for type 2-diabetes and cardiovascular disease within these populations.

Obese children have gained incredible national attention as of late. Recent data have shown that 34 percent of Hispanic adolescents and 37 percent of African-American adolescents are considered at risk of being overweight, says Goran. The new center for minority health is a collaborative effort between USC and Childrens Hospital Los Angeles to research and develop preventive strategies to offset the obesity epidemic.

The USC Comprehensive Center of Excellence in Minority Health is one of 13 institutions across the country supported by NCMHD to conduct research exploring the multiple and complex factors contributing to minority health disparities. The center will consist of programs designed to analyze fitness activity, nutrition education and body weight to determine if long-term control of obesity and obesity-related diseases in minority children can be addressed before adulthood.

We are very pleased to see that Michael Goran has been awarded this grant. His commitment and dedication to childhood obesity research continuously contribute to better management of this condition, says Brian Henderson, M.D., dean of the Keck School of Medicine of USC. We
'/>"/>

Contact: Jennifer Chan
chanj@usc.edu
323-442-2830
University of Southern California
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)... secondary life insurance market ranked 156 among ...merica on Inc. 500 list, BETHESDA, Md., Aug. 20 /...in the secondary life insurance market, announced ...ing insurance related company in the US by,Inc. ma...8 Inc. 500 list of,fastest growing companies in Am...
(Date:8/20/2008)...esidents Gain Access to High Quality Care as State...g. 20 /PRNewswire-USNewswire/ -- Patients who suff...splant will no longer have to,seek that highly spe...p,care outside the borough of the Bronx. Area pati...gh-quality care locally, without having to travel,...
(Date:8/20/2008)...PRINGS, Pa., Aug. 20 /PRNewswire-USNewswire/ -- Go... agricultural industry is struggling,with high fue...ng the need,to secure the state,s energy independe...g adults., Nearly 900 guests gathered to hear the...ay Luncheon at Ag Progress Days, Pennsylvania,s,la...
(Date:8/20/2008)...n of brown globules helps burn calories, hints of ..., Aug. 20 (HealthDay News) -- A protein that induc...good" brown fat that helps burn calories and plays...he Joslin Diabetes Center in Boston. , They sai...ay help lead to new ways to prevent and treat obes...
Breaking Medicine News(10 mins):Health News:Integrity Capital Partners Ranked 2nd Fastest Growing Insurance Related Company in US by Inc. Magazine 2Health News:Liver Transplant Program Established At Montefiore 2Health News:Liver Transplant Program Established At Montefiore 3Health News:Liver Transplant Program Established At Montefiore 4Health News:Pennsylvania Governor Rendell Highlights Renewable Energy, Health Care Reform at Ag Progress Days 2Health News:Bone Growth Protein Also Promotes 'Good' Fat 2
...alth System have identified, for the first time ev...ry the genes for nicotine// dependence (ND) in an ...ome-wide study of such linkage and included the la...n this type of linkage study. Until this study, pa...
... and dedication, have led their families to far aw...s with their men content to play// house-husband. ...essful man, there is a woman' - to read - 'There i...y of each family' to suit the European Malayalis. ...
...rtly after being admitted to a Jakarta hospital te...'s human toll from the H5N1 virus to 51, health of...uburb in southern Jakarta, died less than an hour ...o Infectious Disease Hospital last week, which is ...
... of medical specialists and provide special allowa... to provide due healthcare to people. "Providing ...priority of the state government and for this the ...es to doctors posted in rural areas. If needed, sp...
Other Medicine News:Health News:Researchers Locate Genetic Link for Nicotine Dependence Among African Americans 2Health News:Malayali Nurses - Lifeline of Keralites Abroad 2Health News:Malayali Nurses - Lifeline of Keralites Abroad 3
(Date:8/14/2008)... development to begin in late 2008 or in early 200...tCall/ -- Nuvelo, Inc.,(Nasdaq: NUVO ) today anno...concept trial of NU172, demonstrating that the dir...ined anticoagulation with a rapid,return toward ba...afety,profile., "NU172 has the potential to addre...
(Date:8/13/2008)... Fat Intake Improves Insulin Sensitivity and Reduc...ine Responsiveness, PHOENIX, Aug. 13 /PRNewswire-...Kronos Longevity Research Institute (KLRI) found t...nsitivity and reduces inflammatory,markers, but do...was,recently published in Hormones and Metabolic R...
(Date:8/13/2008)...CRP with ISIS 353512 could provide therapeutic ben...mmatory diseases, CARLSBAD, Calif., Aug. 13 /PRNe...asdaq: ISIS ) announced today it has initiated a,...at inhibits the,production of C-reactive protein (...ts with a variety of diseases including cardiovasc...
(Date:8/12/2008)...alif., Aug. 12 /- DURECT Co...e US Food and Drug Administration,(FDA) has accept... granted,Priority Review. The FDA typically grants...potential to demonstrate significant improvements,...mpleting review of a drug,with Priority Review sta...
Breaking Medicine Technology:Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4Study Shows Benefits of a High Omega-3 Diet in Older Adults 2Study Shows Benefits of a High Omega-3 Diet in Older Adults 3Isis Initiates Clinical Trial of CRP Drug 2Isis Initiates Clinical Trial of CRP Drug 3REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted 2REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted 3Capital BlueCross Receives Prestigious Brand Excellence Award From The Blue Cross 26 Blue Shield Association 14353 1Capital BlueCross Receives Prestigious Brand Excellence Award From The Blue Cross 26 Blue Shield Association 14353 2Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 1Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 2Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 3Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 4Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 5Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 1Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 2Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 3Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 4Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 5Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 6Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 7Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 1Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 2Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 3Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 4Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 5Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 6
...ALEIGH, N.C., April 18, 2007 /PRNewswire/ -- Micel...ll be presenting,data on use of its supercritical ...ug-eluting stents at the upcoming Society for,Biom...Chicago,Illinois. , The abstracts describe use of... e-RESS technology to create drug-eluting stents,c...
...ta Reported at American Association for Cancer Res...RNewswire-FirstCall/ -- Favrille,Inc. , a biophar...tive immunotherapies for the treatment of cancer, ...d activity from insect-cell,derived idiotype (Id) ...immunotherapy product candidate FavId(R) for B-cel...
Other Medicine Technology:Micell Technologies Presents Data on Novel Drug-Eluting Stents 2Micell Technologies Presents Data on Novel Drug-Eluting Stents 3Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 2Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 3Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 4
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: